lactic acid has been researched along with piroxicam in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bracht, A; Constantin, J; Ishii-Iwamoto, EL; Nascimento, EA; Salgueiro-Pagadigorria, CL | 1 |
| Guinzberg, R; Piña, E; Rocha-Hernández, A; Saldaña-Balmori, Y; Zentella de Piña, M | 1 |
| Guinzberg, R; Julián-Sánchez, A; Piña, E; Riveros-Rosas, H; Saavedra-Molina, A; Saldaña-Balmori, Y; Zentella de Piña, M | 1 |
| Berkland, C; Cox, A; Kim, K; King, M; Pack, DW | 1 |
| Kim, KK; Pack, DW; Pollauf, EJ | 1 |
| Andrews, MJ; Berchane, NS; Carson, KH; Rice-Ficht, AC | 1 |
| Della Porta, G; Reverchon, E | 1 |
| Puthli, S; Vavia, PR | 1 |
| Della Porta, G; Falco, N; Reverchon, E | 1 |
| Carrupt, PA; Delie, F; Domańska, U; Martel, S; Pelczarska, A | 1 |
| Aruta, MG; Baldi, A; Barba, V; Crispi, S; Diano, N; Favicchia, I; Menale, C; Mita, DG; Nicolucci, C; Piccolo, MT | 1 |
| Fahr, A; Fariya, MK; Nagarsenker, MS; Rajawat, GS; Steiniger, F; Varghese, SE | 1 |
| Abdel Hamid, MA; Elkasabgy, NA; Gawdat, SI; Kataia, MM; Mahmoud, AA; Shamma, RN | 1 |
| Jensen, H; Larsen, SW; Petersen, NJ; Sun, Y; Østergaard, J | 1 |
15 other study(ies) available for lactic acid and piroxicam
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of the nonsteroidal anti-inflammatory drug piroxicam on energy metabolism in the perfused rat liver.
Topics: Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimycin A; Atractyloside; Drug Interactions; Energy Metabolism; Fasting; Gluconeogenesis; Glucose; Glycogen; Lactates; Lactic Acid; Liver; Male; Mitochondria, Liver; NAD; NADP; Oxygen Consumption; Perfusion; Piroxicam; Pyruvates; Pyruvic Acid; Rats; Rats, Wistar | 1996 |
Piroxicam modifies the effects of ethanol on isolated rat hepatocytes.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Epinephrine; Ethanol; Lactic Acid; Liver; Male; Piroxicam; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 1996 |
Antagonism between the metabolic responses induced by epinephrine and piroxicam on isolated rat hepatocytes.
Topics: Adenosine Diphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Drug Interactions; Epinephrine; Ethanol; Glucose; Lactic Acid; Liver; Male; Mitochondria, Liver; Oxygen Consumption; Piroxicam; Rats; Rats, Wistar; Triglycerides | 1999 |
Precise control of PLG microsphere size provides enhanced control of drug release rate.
Topics: Biocompatible Materials; Chemical Phenomena; Chemistry, Physical; Kinetics; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Particle Size; Piroxicam; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rhodamines | 2002 |
Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
Topics: Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Lactic Acid; Microscopy, Confocal; Microscopy, Electron, Scanning; Microspheres; Particle Size; Piroxicam; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Time Factors | 2005 |
Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
Topics: Chemistry, Pharmaceutical; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Compounding; Kinetics; Lactic Acid; Microspheres; Models, Chemical; Particle Size; Piroxicam; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Reproducibility of Results; Solubility; Surface Properties; Technology, Pharmaceutical | 2007 |
Nanostructured microspheres produced by supercritical fluid extraction of emulsions.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Capsules; Chromatography, Supercritical Fluid; Diffusion; Drug Carriers; Drug Compounding; Emulsions; Lactic Acid; Materials Testing; Nanostructures; Particle Size; Piroxicam; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2008 |
Stability studies of microparticulate system with piroxicam as model drug.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Stability; Excipients; Humidity; Injections; Kinetics; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Particle Size; Pharmaceutical Preparations; Piroxicam; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solvents; Spectroscopy, Fourier Transform Infrared; Syringes; X-Ray Diffraction | 2009 |
NSAID drugs release from injectable microspheres produced by supercritical fluid emulsion extraction.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Carbon Dioxide; Chromatography, Supercritical Fluid; Diclofenac; Drug Carriers; Drug Compounding; Emulsions; Lactic Acid; Microspheres; Particle Size; Piroxicam; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties | 2010 |
New high throughput screening method for drug release measurements.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Automation, Laboratory; Chemical Phenomena; Delayed-Action Preparations; Drug Compounding; Filtration; High-Throughput Screening Assays; Kinetics; Lactic Acid; Microchemistry; Microscopy, Electron, Scanning; Microspheres; Particle Size; Piroxicam; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quality Control; Reproducibility of Results; Solubility; Surface Properties | 2013 |
Efficacy of piroxicam plus cisplatin-loaded PLGA nanoparticles in inducing apoptosis in mesothelioma cells.
Topics: Apoptosis; Cell Line, Tumor; Cisplatin; Drug Carriers; Drug Combinations; Humans; Lactic Acid; Mesothelioma; Nanoparticles; Piroxicam; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Treatment Outcome | 2015 |
Lecithin and PLGA-based self-assembled nanocomposite, Lecithmer: preparation, characterization, and pharmacokinetic/pharmacodynamic evaluation.
Topics: Animals; Cell Survival; Cells, Cultured; Daunorubicin; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Edema; Humans; Lactic Acid; Lecithins; Male; Nanocomposites; Piroxicam; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats | 2016 |
Design of novel injectable in-situ forming scaffolds for non-surgical treatment of periapical lesions: In-vitro and in-vivo evaluation.
Topics: Animals; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Dogs; Injections; Lactic Acid; Male; Periapical Diseases; Piroxicam; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Risedronic Acid; Solubility; Sucrose; Tissue Scaffolds; Viscosity | 2017 |
Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV-vis imaging.
Topics: Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Drug Implants; Drug Liberation; Hydrogels; Lactalbumin; Lactic Acid; Piroxicam; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones; Spectrophotometry, Ultraviolet; Spectrum Analysis; Subcutaneous Tissue; Triacetin | 2018 |